Related stories
MPLX Reports Nine-Month Revenue of $3.61B and EPS of $1.15
MPLX reported 2026 nine-month revenue of $3.61 billion, down 0.4% from a year earlier. Net income fell 24.5% to $1.17 billion and diluted EPS declined 24.3% to $1.15.
M impact | EARNINGS | Nov 03, 2026, 06:11 PM UTC
Revvity set for best day in over 16 years after beating Q3 forecasts
Revvity is poised for its strongest one-day performance in more than 16 years after exceeding third-quarter forecasts.
M impact | EARNINGS | Nov 03, 2026, 06:06 PM UTC
Revvity shares reach 16-year high after third-quarter results top estimates
Revvity shares reached a 16-year high after third-quarter results topped expectations.
M impact | EARNINGS | Nov 03, 2026, 06:05 PM UTC
Revvity Shares Set for Best Day in Over 16 Years After Q3 Beat
Revvity shares are set for their best day in over 16 years after the company beat in the third quarter.
M impact | EARNINGS | Nov 03, 2026, 06:05 PM UTC
Strata Critical Medical Reports 2026 Revenue of $74.08 Million
Quarterly revenue rose from $49.3 million a year earlier, while the company reported a net loss of $7.62 million versus net income of $57.42 million. Diluted EPS was a loss of $0.0
M impact | EARNINGS | Nov 03, 2026, 05:51 PM UTC
Broadridge Reports 2026 Revenue of $1.67B, EPS of $0.83
Revenue rose 5% year over year to $1.67 billion, while net income fell 42.7% to $94.8 million and diluted EPS declined 40.7% to $0.83. Recurring revenue growth across ICS and GTO s
M impact | EARNINGS | Nov 03, 2026, 05:51 PM UTC